Sun G - Search Results

1

Predicting abiraterone efficacy in advanced prostate cancer: Insights from marker of proliferation Ki67.

Zhao F, Zhao J, Wei X, Shi Y, Xu N, Zhu S, Chen J, Sun G, Dai J, Wang Z, Zhang X, Liang J, Hu X, Liu H, Zhao J, Liu Z, Nie L, Shen P, Chen N, Zeng H. Zhao F, et al. Among authors: sun g. Prostate. 2024 Apr 17. doi: 10.1002/pros.24710. Online ahead of print. Prostate. 2024. PMID: 38629249

2

The impact of multifocal perineural invasion on biochemical recurrence and timing of adjuvant androgen-deprivation therapy in high-risk prostate cancer following radical prostatectomy.

Sun G, Huang R, Zhang X, Shen P, Gong J, Zhao J, Liu J, Tang Q, Shu K, Yin X, Chen N, Zeng H. Sun G, et al. Prostate. 2017 Sep;77(12):1279-1287. doi: 10.1002/pros.23388. Epub 2017 Jul 27. Prostate. 2017. PMID: 28752514

3

AKR1C3 expression in primary lesion rebiopsy at the time of metastatic castration-resistant prostate cancer is strongly associated with poor efficacy of abiraterone as a first-line therapy.

Zhao J, Zhang M, Liu J, Liu Z, Shen P, Nie L, Guo W, Cai D, Liu J, Armstrong CM, Sun G, Chen J, Zhu S, Dai J, Zhang H, Zhao P, Zhang X, Yin X, Zhu X, Ni Y, Chen N, Zeng H. Zhao J, et al. Among authors: sun g. Prostate. 2019 Sep;79(13):1553-1562. doi: 10.1002/pros.23875. Epub 2019 Jul 11. Prostate. 2019. PMID: 31294486

4

Does ductal adenocarcinoma of the prostate (DA) have any prognostic impact on patients with de novo metastatic prostate cancer?

Wu T, Zhao J, Liu Z, Shen P, Zhang M, Sun G, Liu J, Liao B, Chen J, Zhu S, Dai J, Wang Z, Zhang H, Zhao P, Zhang X, Zhu X, Ni Y, Chen N, Zeng H. Wu T, et al. Among authors: sun g. Prostate. 2019 Oct;79(14):1673-1682. doi: 10.1002/pros.23892. Epub 2019 Aug 21. Prostate. 2019. PMID: 31433509

5

Dynamic multidisciplinary team discussions can improve the prognosis of metastatic castration-resistant prostate cancer patients.

Zhu S, Chen J, Ni Y, Zhang H, Liu Z, Shen P, Sun G, Liang J, Zhang X, Wang Z, Wei Q, Li X, Chen N, Li Z, Wang X, Shen Y, Yao J, Huang R, Liu J, Cai D, Zeng H. Zhu S, et al. Among authors: sun g. Prostate. 2021 Aug;81(11):721-727. doi: 10.1002/pros.24167. Epub 2021 May 24. Prostate. 2021. PMID: 34028061 Free PMC article.

6

Exosomal TUBB3 mRNA expression of metastatic castration-resistant prostate cancer patients: Association with patient outcome under abiraterone.

Zhu S, Ni Y, Sun G, Wang Z, Chen J, Zhang X, Zhao J, Zhu X, Dai J, Liu Z, Liang J, Zhang H, Zhang Y, Shen P, Zeng H. Zhu S, et al. Among authors: sun g. Cancer Med. 2021 Sep;10(18):6282-6290. doi: 10.1002/cam4.4168. Epub 2021 Jul 28. Cancer Med. 2021. PMID: 34318630 Free PMC article.

7

The heterogeneity of intraductal carcinoma of the prostate is associated with different efficacy of standard first-line therapy for patients with metastatic castration-resistant prostate cancer.

Wang Z, Zhu S, Zhao J, Nie L, Chen X, Zhang M, Chen N, Sun G, Chen J, Ni Y, Dai J, Liu Z, Tao R, Zhang X, Zhu X, Zhang H, Liang J, Wang Z, He B, Shen P, Zeng H. Wang Z, et al. Among authors: sun g. Prostate. 2021 Nov;81(15):1191-1201. doi: 10.1002/pros.24215. Epub 2021 Aug 26. Prostate. 2021. PMID: 34435696 Free PMC article.

8

Neuroendocrine differentiation predicts the therapeutic efficacy of abiraterone and docetaxel as first-line therapy in metastatic castration-resistant prostate cancer.

Xu N, Zhao J, Zhao F, Liu H, Yin W, Zhu S, Nie L, Sun G, Zheng L, Liu Z, Cai D, Chen J, Dai J, Ni Y, Wang Z, Zhang X, Liang J, Chen Y, Hu X, Pan X, Yin X, Zhu X, Zhang Y, Wang Z, Zeng Y, Wang M, Shen P, Chen N, Zeng H. Xu N, et al. Among authors: sun g. J Cancer Res Clin Oncol. 2023 Aug;149(10):7247-7258. doi: 10.1007/s00432-023-04639-9. Epub 2023 Mar 13. J Cancer Res Clin Oncol. 2023. PMID: 36907910

9

Predictive efficacy of the 2014 International Society of Urological Pathology Gleason grading system in initially diagnosed metastatic prostate cancer.

Sun GX, Shen PF, Zhang XM, Gong J, Gui HJ, Shu KP, Liu JD, Zhao J, Yang YJ, Chen XQ, Chen N, Zeng H. Sun GX, et al. Asian J Androl. 2017 Sep-Oct;19(5):573-578. doi: 10.4103/1008-682X.186184. Asian J Androl. 2017. PMID: 27569001 Free PMC article.

10

The association between SPINK1 and clinical outcomes in patients with prostate cancer: a systematic review and meta-analysis.

Zhang X, Yin X, Shen P, Sun G, Yang Y, Liu J, Chen N, Zeng H. Zhang X, et al. Among authors: sun g. Onco Targets Ther. 2017 Jun 22;10:3123-3130. doi: 10.2147/OTT.S127317. eCollection 2017. Onco Targets Ther. 2017. PMID: 28790846 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9,737 results

Search Page